Table 3 |
||||
|
Hazard ratios for genotypes rs10818488 and rs2416808 in the RA-cohort and Non-RA cohort in univariate cox regression analysis |
||||
|
Hazard ratios RA cohort |
||||
|
|
||||
|
Trend |
AA vs GG |
|||
|
|
|
|||
|
Mortality |
HR(95% CI) |
P value |
HR (95% CI) |
P value |
|
|
||||
|
All-cause |
1.06 (0.76-1.46) |
0.752 |
1.08 (0.54-2.15) |
0.830 |
|
CVD |
0.91 (0.53-1.54) |
0.713 |
0.81 (0.27-2.43) |
0.712 |
|
Cancer |
0.90 (0.49-1.67) |
0.741 |
0.73 (0.18-2.92) |
0.657 |
|
Infectious |
1.19 (0.41-3.51) |
0.748 |
1.42 (0.09-22.7) |
0.803 |
|
|
||||
|
Hazards ratios non-RA cohort |
||||
|
|
||||
|
Trend |
GG vs AA |
|||
|
|
|
|||
|
Mortality |
HR (95% CI) |
P value |
HR (95% CI) |
P value |
|
|
||||
|
All-cause |
0.99 (0.89-1.11) |
0.890 |
0.99 (0.79-1.25) |
0.924 |
|
CVD |
0.95 (0.80-1.12) |
0.512 |
0.89 (0.64-1.25) |
0.515 |
|
Cancer |
1.00 (0.82-1.21) |
0.980 |
1.02 (0.70-1.50) |
0.919 |
|
|
||||
|
CI, confidence interval; HR, hazard ratio; CVD, cardiovascular disease; RA, rheumatoid arthritis. |
||||
|
van Nies et al. Arthritis Research & Therapy 2010 12:R38 doi:10.1186/ar2947 |
||||